Amniotic Stem Cells for Sale Online?

by Chris Centeno, MD /

amniotic-stem-cells-for-saleOn Friday I fielded a patient question and saw a Google ad for amniotic stem cells for sale that were both a demonstration of how the orthopedic stem cell field that I helped create has become a mess. In particular, the ad that popped up in my browser shows a very scary new trend, one that may mean that all stem cell treatments for all patients get further curtailed by the FDA. Let me explain.

The Patient Question That Exposed the Amniotic Mess

Given that I started orthopedic stem cell injections for most orthopedic conditions in 2005, it’s strange to see this field evolving in both some good and some appalling ways. Take, for example, the amniotic “stem cell” scams sweeping the nation. I’ve discussed many times how physicians and chiropractors alike are misleading patients that they are getting live stem cell injections and performing dead cell injections. When this all began, there was little information on what these vials of amniotic tissue contained, so the benefit of the doubt could be given to these healthcare providers. However, in 2016, it’s easy enough to find out that these amniotic “stem cell” products don’t contain live cells, so the clinics and companies selling them as stem cell products should know better.

On Friday I answered a patient question about why an amniotic “stem cell” injection was cheaper than a bone marrow stem cell procedure. I promptly informed the patient that there were no live and viable cells in the amniotic stem cell injection and that the shot he was offered was closer to a platelet rich plasma (PRP) injection, primarily a growth-factor cocktail. Hence, at $4,000, he was paying about 3–4 times as much for a growth-factor shot when compared to a much less expensive PRP injection.

How We Got Here Is Shown by a Disturbing New Ad

Earlier in the week, while preparing a lecture, I ran a Google search to try and find an amniotic stem cell image for the talk. This amniotic stem cells for sale sponsored ad came up:

“Amniotic Stem Cell Supplier—Live Stem Cells, Low Pricing.‎
Ad www.amnio…products.com/(8…) 43..-7..6
Buy cryopreserved amniotic stem cell products. Live cell counts, FDA Regulated.”
Given that we often use cells for research purposes in our Regenexx stem cell research facility, I clicked on it, expecting to find one of the scientific supply houses vending cells for “research use only.” What I found was far more ominous. Instead of a science supply company, I found one of the amniotic “stem cell” clinic outfits that is misleading the public by claiming that the dead tissue it injects has live and viable amniotic “stem cells.” Instead of a clinic ad, what I found was a company hawking amniotic stem cells for sale. Yikes! So not only are these companies misrepresenting what they are injecting but now they’re placing ads in Google meant for physicians, claiming to sell live cells, in direct violation of all FDA rules on the subject!

Why Is This Latest Trend Very Scary and Very Different?

Physicians have broad discretion over what is the practice of medicine. For example, a doctor using a procedure in a given patient that uses that patient’s tissue is dramatically different from a regulatory standpoint than a supplier of drug products that’s selling allogeneic products online to any willing physician buyer. In this particular case, there is little doubt that the amniotic tissue supplier described above is an FDA-regulated entity and as such, would need a 351 drug approval to sell live cells to physicians for therapeutic purposes. Why? Isn’t this company already FDA regulated? Not for what’s being advertised and sold.
In the analysis of whether these amniotic stem cells for sale that are being promoted as loosely regulated tissues should be instead much more strictly regulated as drugs, the claims made about this product become critical. If the claims simply discuss that the tissue is processed this way or that, no problems. However, once claims are made about live cells and how those cells may cure disease, that’s different. Here are some claims made at this website:
“Amniotic stem cell therapy is now mainstream and it works very well for many medical conditions. The product we offer has LIVE stem cells with certified cell counts and is processed at an FDA regulated lab that is also AATB Certified. We can meet or beat your current pricing over 95% of the time!”
The claims:
1. Amniotic stem cell therapy is effective for many medical conditions.
2. The product has live stem cells.
Regardless of whether this product has live stem cells (given what we’ve seen, it would be very unlikely that it had live stem cells that were capable of anything other than becoming quickly apoptotic or dying), the claim that this product has them changes the regulatory status. These claims move it from a voluntary and inexpensive 361 tissue registration into the world of an expensive and strictly regulated 351 drug.
Here are more examples:

Conditions Treated

  • Musculoskeletal and Spine 
  • Orthopedics & Pain Management
  • Wound Healing Issues
  • Hair Restoration
  • Cosmetic Indications
  • Systemic Issues

Depending on how you read this, this product is being offered to treat at least 5 or 6 to 20 or more medical indications. Again, all claims that for an FDA-regulated product transform it from a 361 tissue into a 351 drug.

Now that we know that this product is not a loosely regulated tissue but instead a controlled drug, the big problem becomes that this drug product has no FDA approval. Since this distinction is where both physicians and patients get confused, let’s delve a little deeper into the differences. The gulf between what a 361 tissue registration entails and a 351 drug product needs for approval is broad and deep.

The ad copy claims that this product is FDA regulated, but while that’s technically correct, when you understand cell drug regulation, it’s deceiving. The 361 tissue registration filed for this product is an online form that’s filled out by the manufacturer. There are no clinical trials required nor drug approval process. Submit the form, and you’re done.

Contrast that simple 361 registration to a highly complicated, expensive, and time-consuming FDA cell drug approval. For the latter, there are preclinical experiments in animals that must be performed costing $1–3 million. Then the manufacturer must file for a biologics license, which will easily cost another $2–3 million. Then phase-1 trials will run another $1–3 million, phase-2 trials another $5–20 million, and phase-3 trials yet another $20-300 million. All of this takes somewhere around a decade to complete.

Also, while the physical site where these amniotic products are processed may have an AATB (American Association of Tissue Banks) registration, that means nothing to FDA if this tissue is considered a drug product. That’s because drugs are manufactured under much more stringent cGMP (current Good Manufacturing Practices). Any AATB site would fail a cGMP inspection across the board, as these drug-manufacturing regulations are far more extreme than a tissue processor could handle. Also, any surgery center or hospital would also fail.

In summary, the simple online registration that this amniotic product claims pales in comparison to an actual drug approval. Once this product is determined to be a 351 drug and not a 361 tissue (the existing voluntary registration), it needs a separate, full 3-phase and hugely expensive drug approval trial for every medical indication listed!

Why This New Trend Is Not Good for the Field

Physicians who are legitimately trying to use the patient’s stem cells or other autologous tissues to help patients have long argued that this is the practice of medicine and that the FDA has no right entering the regulation of medical practices. Many credible and compelling arguments can be made that the FDA is overstepping the law by regulating autologous tissues used by doctors as drugs. In fact, an impressive array of luminaries and experts showed up at the FDA hearing last month to argue just that. However, this new ploy to sell unapproved allogeneic stem cell products direct to physicians gives the FDA exactly what it needs to render meaningless all of the hard work that went into the effort to support a patient’s right to use his or her body parts. Why? While there is little doubt that the FDA doesn’t regulate the practice of medicine, there is also little doubt that it does control allogeneic tissues and cells. Hence, an entrepreneur trying to sell unapproved cell drug products online to any willing buyer gives the FDA the high ground in the argument against allowing any stem cell treatments to be performed. Why? They can now point to an area they clearly regulate and say with a straight face, “Look at how out of hand this stem cell treatment space has become.”

The upshot? This online amniotic tissue sales scheme is a new twist in the never-ending saga of consumer-level fraud that’s occurring with amniotic products. On the one hand, these products may contain important growth factors and may work more or less like an expensive PRP shot. On the contrary, they’re clearly not stem cell products. Now, by selling these products directly to physicians online and claiming that they have live cells that are effective for many indications, a new bright line has been crossed. No longer is the issue the physician’s right to use the patient’s cells the universal and compelling rallying call. Instead, the FDA has been provided with ample evidence that tighter regulation is required to rein in an “out of control” free-for-all stem cell treatment space.

Category: Latest News

Leave a Reply

Your email address will not be published. Required fields are marked *

1 thought on “Amniotic Stem Cells for Sale Online?

  1. Nina Martin

    Two friends and I went to a lecture-given at a retirement community about using stem cells from baby placentas instead of our own, because-as she said-wouldn’t you rather have fresh stem cells from a newborn baby instead of stem cells from your own 50 plus years body? This woman lectures this stuff all over around here. She is a chiropractor who probably went to a weekend training for this. She owns a wellness clinic and I was seeing her physical therapist who is a young gal, very nice. I tried to explain to this therapist why that couldn’t work-I have been following Regenexx for over a year, but she is thoroughly convinced that baby placenta stem cells are the way to go, and I hear hospitals are making fortunes selling these placentas. So, so sad. I’m amazed that these practices are allowed.

Chris Centeno, MD

Regenexx Founder

Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications.
View Profile

Get Blog Updates by Email

Get fresh updates and insights from Regenexx delivered straight to your inbox.

Regenerative procedures are commonly used to treat musculoskelatal trauma, overuse injuries, and degenerative issues, including failed surgeries.
Select Your Problem Area
Shoulder

Shoulder

Many Shoulder and Rotator Cuff injuries are good candidates for regenerative treatments. Before considering shoulder arthroscopy or shoulder replacement, consider an evaluation of your condition with a regenerative treatment specialist.

  • Rotator Cuff Tears and Tendinitis
  • Shoulder Instability
  • SLAP Tear / Labral Tears
  • Shoulder Arthritis
  • Other Degenerative Conditions & Overuse Injuries
Learn More
Cervical Spine

Spine

Many spine injuries and degenerative conditions are good candidates for regenerative treatments and there are a number of studies showing promising results in treating a wide range of spine problems. Spine surgery should be a last resort for anyone, due to the cascade of negative effects it can have on the areas surrounding the surgery. And epidural steroid injections are problematic due to their long-term negative impact on bone density.

  • Herniated, Bulging, Protruding Discs
  • Degenerative Disc Disease
  • SI Joint Syndrome
  • Sciatica
  • Pinched Nerves and General Back Pain
  • And more
Learn More
Knee

Knees

Knees are the target of many common sports injuries. Sadly, they are also the target of a number of surgeries that research has frequently shown to be ineffective or minimally effective. Knee arthritis can also be a common cause for aging athletes to abandon the sports and activities they love. Regenerative procedures can be used to treat a wide range of knee injuries and conditions. They can even be used to reduce pain and delay knee replacement for more severe arthritis.

  • Knee Meniscus Tears
  • Knee ACL Tears
  • Knee Instability
  • Knee Osteoarthritis
  • Other Knee Ligaments / Tendons & Overuse Injuries
  • And more
Learn More
Lower Spine

Spine

Many spine injuries and degenerative conditions are good candidates for regenerative treatments and there are a number of studies showing promising results in treating a wide range of spine problems. Spine surgery should be a last resort for anyone, due to the cascade of negative effects it can have on the areas surrounding the surgery. And epidural steroid injections are problematic due to their long-term negative impact on bone density.

  • Herniated, Bulging, Protruding Discs
  • Degenerative Disc Disease
  • SI Joint Syndrome
  • Sciatica
  • Pinched Nerves and General Back Pain
  • And more
Learn More
Hand & Wrist

Hand & Wrist

Hand and wrist injuries and arthritis, carpal tunnel syndrome, and conditions relating to overuse of the thumb, are good candidates for regenerative treatments. Before considering surgery, consider an evaluation of your condition with a regenerative treatment specialist.
  • Hand and Wrist Arthritis
  • Carpal Tunnel Syndrome
  • Trigger Finger
  • Thumb Arthritis (Basal Joint, CMC, Gamer’s Thumb, Texting Thumb)
  • Other conditions that cause pain
Learn More
Elbow

Elbow

Most injuries of the elbow’s tendons and ligaments, as well as arthritis, can be treated non-surgically with regenerative procedures.

  • Golfer’s elbow & Tennis elbow
  • Arthritis
  • Ulnar collateral ligament wear (common in baseball pitchers)
  • And more
Learn More
Hip

Hip

Hip injuries and degenerative conditions become more common with age. Do to the nature of the joint, it’s not quite as easy to injure as a knee, but it can take a beating and pain often develops over time. Whether a hip condition is acute or degenerative, regenerative procedures can help reduce pain and may help heal injured tissue, without the complications of invasive surgical hip procedures.

  • Labral Tear
  • Hip Arthritis
  • Hip Bursitis
  • Hip Sprain, Tendonitis or Inflammation
  • Hip Instability
Learn More
Foot & Ankle

Foot & Ankle

Foot and ankle injuries are common in athletes. These injuries can often benefit from non-surgical regenerative treatments. Before considering surgery, consider an evaluation of your condition with a regenerative treatment specialist.
  • Ankle Arthritis
  • Plantar fasciitis
  • Ligament sprains or tears
  • Other conditions that cause pain
Learn More

Is Regenexx Right For You?

Request a free Regenexx Info Packet

REGENEXX WEBINARS

Learn about the #1 Stem Cell & Platelet Procedures for treating arthritis, common joint injuries & spine pain.

Join a Webinar

RECEIVE BLOG ARTICLES BY EMAIL

Get fresh updates and insights from Regenexx delivered straight to your inbox.

Subscribe to the Blog

FOLLOW US

Copyright © Regenexx 2019. All rights reserved. | Privacy Policy

*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.